HomeOwner SearchCategory Search
Visit USCOAdverse Events: Race, Inequality, and the Testing of New Pharmaceuticals
![hero image](/_next/image?url=%2Fimages%2FCRLogo.png&w=384&q=75)
Text Registration
Copyright Title
Adverse Events: Race, Inequality, and the Testing of New Pharmaceuticals
Status
Published
on 22 Dec 2020
Year of Creation
2020
Copyright Claimant
New York University
Registration Number
TX0008929216
on 22 Dec 2020Copyright Summary
The U.S. Copyright record (Registration Number: TX0008929216) dated 22 Dec 2020, pertains to an electronic file (eService) titled "Adverse Events: Race, Inequality, and the Testing of New Pharmaceuticals" created in 2020. The copyright holder is New York University, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to New York University.
Application Details
Registration Number
TX0008929216
Registration Date
12/22/2020
Year of Creation
2020
Agency Marc Code
DLC-CO
Record Status
New
Physical Description
Electronic file (eService)
First Publication Nation
United States
Statements
Application Title Statement: Adverse Events: Race, Inequality, and the Testing of New Pharmaceuticals
Author Statement: Jill A. Fisher Citizenship: United States Authorship: text
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.